Chronic infections and coronary heart disease

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Venezuela: violence, human rights, and health-care realities
Pathogenesis of urinary tract infections with normal female anatomy
ZIKA App – A great resource from the World Health Organization (WHO)
Volume 376, Issue 9755, Pages (November 2010)
The epidemic of chronic kidney disease in Central America
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes  Edy Kornelius, MD, Jeng-Yuan Chiou, PhD, Yi-Sun Yang, PhD, MD,
The benefits and harms of breast cancer screening
Simple versus complex COPD: implications for health-care management
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
The Secret Life of America's Poison Centers
Cardiovascular disease
Infections related to totally implantable venous-access ports
Advances in pediatric asthma in 2011: Moving forward
Regulating illegal drug markets: what legal markets can teach us
Frailty assessment in elderly people
Cardiovascular disease
Long-term effects of hormone replacement therapy
Mortality in people with mental disorders in the Czech Republic: a nationwide, register- based cohort study  Dzmitry Krupchanka, PhD, Karolína Mladá, MA,
Trends in primary liver cancer
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations  Judith A. Finegold,
WHO's budgetary allocation and disease burden
Genetics of lung cancer susceptibility and COPD
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Myth of the menopause paradox
Ageing in the 21st century
Increase in US medication-error deaths
Keeping pace with population growth
Advancing asthma care: The glass is only half full!
Organisation of the care of patients with heart failure
Disease and stigma The Lancet Volume 354, (December 1999)
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK  Krishnan Bhaskaran, PhD,
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
Arnaud Chiolero  The Lancet Public Health 
Jonathan Broad, Matthew D Snape  The Lancet Public Health 
Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030  Eduardo.
Volume 352, Pages S15-S18 (October 1998)
Low-level lead exposure and mortality in US adults: a population-based cohort study  Prof Bruce P Lanphear, MD, Stephen Rauch, MPH, Peggy Auinger, MS,
A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro 
Metabolic mediators of body-mass index and cardiovascular risk
Confessions of a journal junkie
Errata The Lancet Infectious Diseases
Telling it like it isn't: truth and lies in a post-9/11 world
Availability of essential diagnostics in primary care in India
Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha 
Thank God for Richard Dawkins?
Low-technology approaches
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
The future of medical journals in the western world
Thank you to our diverse (but not diverse enough) reviewers
Genital herpes—how much of a public-health problem?
The 2009 influenza pandemic
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
A remarkable report card on progress in COPD
Ebola control: rapid diagnostic testing
Effects of the 2008 recession on health: a first look at European data
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)
Guidance on research integrity: no union in Europe
Memories of race and place in the USA
Volume 349, Issue 9062, Pages (May 1997)
Jay S. Kaufman, PhD, Sam Harper, PhD  The American Journal of Medicine 
Fighting for health: meet the doctor-activists
Symptom-based stratification of autoimmune diseases
Sickle cell disease: a new era
Autism, maths, and sex: the special triangle
Trends in temperature-related age-specific and sex-specific mortality from cardiovascular diseases in Spain: a national time-series analysis  Hicham Achebak,
Presentation transcript:

Chronic infections and coronary heart disease Gabriel Ånestad, Olad Scheel, Olav Hungnes  The Lancet  Volume 350, Issue 9083, (October 1997) DOI: 10.1016/S0140-6736(97)26040-X Copyright © 1997 Elsevier Ltd Terms and Conditions

Deaths per 100 000 population of cardiovascular diseases* CVD according to ICD9 (International Classification of Diseases, 9th revision) codes 390–459. Standardised on the basis of age at Dec 31, 1990, % of total energy from fat (g fat per 10 MJ), % of smokers (16–74 years), and consumption of tetracycline in defined daily doses (DDD) per 1000. Data obtained from Statistics Norway, Norwegian Nutritional Council, National Council of Tobacco and Health, and Norwegian Medicinal Depot. The Lancet 1997 350, DOI: (10.1016/S0140-6736(97)26040-X) Copyright © 1997 Elsevier Ltd Terms and Conditions